failure to respond or late response
on 26 Feb 2024
Last Applicant/ Owned by
126 EAST LINCOLN AVE.
RAHWAY
NJ
07065
Serial Number
97106884 filed on 03rd Nov 2021
Registration Number
N/A
Correspondent Address
Lisa M. Dellamura
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
The color(s) Swedish Orange is/are claimed as a feature of the mark. pharmaceutical preparations for the treatment of infectious diseases; antivirals; anti-infectives The mark consists of the color Swedish Orange applied to the entire surface of a three-dimensional oblong capsule. The dotted outline of the capsule is intended to show the position of the mark on the goods, and exclusive right is Read More
pharmaceutical preparations for the treatment of infectious diseases; antivirals; anti-infectives
31st Dec 2021
31st Dec 2021
No 97106884
No Service/Collective Mark
No TM2021.141
No
No
No
No
No
No
No
No
10.09.01 -
Medicines and nonmedical products in tablet, capsule or powder form; suppositories
26.11.26 -
Oblongs as carriers for words, letters or designs
26.11.27 -
Oblongs not being used as carriers for words, letters or designs
29.02.07 -
Orange
The mark consists of the color Swedish Orange applied to the entire surface of a three-dimensional oblong capsule. The dotted outline of the capsule is intended to show the position of the mark on the goods, and exclusive right is not claimed to the shape of the capsule itself.
| Status Date | Action Taken |
|---|---|
| 26th Feb 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 26th Feb 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 01st Nov 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 01st Nov 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 10th Aug 2023 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| 09th Aug 2023 | USE AMENDMENT ACCEPTED |
| 09th Aug 2023 | FINAL REFUSAL WRITTEN |
| 09th Aug 2023 | FINAL REFUSAL E-MAILED |
| 09th Aug 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 04th Aug 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
